BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
EPA:BLC - Euronext Paris - Matif - FR0000035370 - Common Stock - Currency: EUR
Overall BLC gets a fundamental rating of 4 out of 10. We evaluated BLC against 24 industry peers in the Health Care Providers & Services industry. BLC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLC has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLC was profitable.
In the past year BLC had a positive cash flow from operations.
Of the past 5 years BLC 4 years were profitable.
In the past 5 years BLC always reported a positive cash flow from operatings.
1.2 Ratios
BLC's Return On Assets of 0.25% is on the low side compared to the rest of the industry. BLC is outperformed by 75.00% of its industry peers.
The Return On Equity of BLC (2.25%) is worse than 75.00% of its industry peers.
BLC has a Return On Invested Capital of 5.65%. This is in the better half of the industry: BLC outperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLC is in line with the industry average of 6.26%.
The 3 year average ROIC (5.34%) for BLC is below the current ROIC(5.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROIC | 5.65% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
1.3 Margins
BLC's Profit Margin of 0.32% is on the low side compared to the rest of the industry. BLC is outperformed by 75.00% of its industry peers.
Looking at the Operating Margin, with a value of 7.67%, BLC is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
BLC's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 67.54%, BLC is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BLC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% |
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLC is still creating some value.
The number of shares outstanding for BLC has been reduced compared to 1 year ago.
Compared to 5 years ago, BLC has about the same amount of shares outstanding.
Compared to 1 year ago, BLC has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.41, we must say that BLC is in the distress zone and has some risk of bankruptcy.
BLC has a Altman-Z score (1.41) which is in line with its industry peers.
BLC has a debt to FCF ratio of 9.33. This is a negative value and a sign of low solvency as BLC would need 9.33 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.33, BLC is in line with its industry, outperforming 50.00% of the companies in the same industry.
BLC has a Debt/Equity ratio of 5.20. This is a high value indicating a heavy dependency on external financing.
BLC has a worse Debt to Equity ratio (5.20) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Altman-Z | 1.41 |
ROIC/WACC1.17
WACC4.83%
2.3 Liquidity
BLC has a Current Ratio of 1.19. This is a normal value and indicates that BLC is financially healthy and should not expect problems in meeting its short term obligations.
BLC has a Current ratio of 1.19. This is in the better half of the industry: BLC outperforms 62.50% of its industry peers.
A Quick Ratio of 0.96 indicates that BLC may have some problems paying its short term obligations.
BLC has a Quick ratio of 0.96. This is comparable to the rest of the industry: BLC outperforms 58.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for BLC have decreased strongly by -72.73% in the last year.
BLC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.24%.
The Revenue has been growing by 9.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-72.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.92%
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
3.2 Future
The Earnings Per Share is expected to grow by 15.74% on average over the next years. This is quite good.
BLC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.06% yearly.
EPS Next Y9.69%
EPS Next 2Y14.54%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue Next Year7.14%
Revenue Next 2Y6.99%
Revenue Next 3Y6.96%
Revenue Next 5Y5.06%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 135.00, BLC can be considered very expensive at the moment.
BLC's Price/Earnings ratio is a bit more expensive when compared to the industry. BLC is more expensive than 75.00% of the companies in the same industry.
BLC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.60.
A Price/Forward Earnings ratio of 8.29 indicates a reasonable valuation of BLC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLC indicates a rather cheap valuation: BLC is cheaper than 95.83% of the companies listed in the same industry.
BLC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.43.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 135 | ||
| Fwd PE | 8.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BLC is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
BLC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BLC is cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.63 | ||
| EV/EBITDA | 5.64 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLC does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BLC's earnings are expected to grow with 15.74% in the coming years.
PEG (NY)13.93
PEG (5Y)N/A
EPS Next 2Y14.54%
EPS Next 3Y15.74%
5. Dividend
5.1 Amount
BLC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:BLC (5/21/2025, 1:13:39 PM)
28.35
-0.05 (-0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.08%
Inst Owner ChangeN/A
Ins Owners1.58%
Ins Owner ChangeN/A
Market Cap208.66M
Analysts83.33
Price Target33.66 (18.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.22
Dividend Growth(5Y)-3.37%
DP42.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.45%
PT rev (3m)15.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-24.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 135 | ||
| Fwd PE | 8.29 | ||
| P/S | 0.39 | ||
| P/FCF | 4.63 | ||
| P/OCF | 1.86 | ||
| P/B | 2.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.64 |
EPS(TTM)0.21
EY0.74%
EPS(NY)3.42
Fwd EY12.06%
FCF(TTM)6.13
FCFY21.61%
OCF(TTM)15.24
OCFY53.74%
SpS73.4
BVpS10.34
TBVpS-19.17
PEG (NY)13.93
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROCE | 8.61% | ||
| ROIC | 5.65% | ||
| ROICexc | 6.05% | ||
| ROICexgc | 11.68% | ||
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% | ||
| FCFM | 8.35% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
ROICexc(3y)5.7%
ROICexc(5y)5.58%
ROICexgc(3y)12.68%
ROICexgc(5y)11.8%
ROCE(3y)8.16%
ROCE(5y)7.93%
ROICexcg growth 3Y11.16%
ROICexcg growth 5Y1.85%
ROICexc growth 3Y8.09%
ROICexc growth 5Y5.81%
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 103.59% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.61% | ||
| Profit Quality | 2640.05% | ||
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.41 |
F-Score6
WACC4.83%
ROIC/WACC1.17
Cap/Depr(3y)89.47%
Cap/Depr(5y)88.81%
Cap/Sales(3y)10.8%
Cap/Sales(5y)10.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.92%
EPS Next Y9.69%
EPS Next 2Y14.54%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
Revenue Next Year7.14%
Revenue Next 2Y6.99%
Revenue Next 3Y6.96%
Revenue Next 5Y5.06%
EBIT growth 1Y3.82%
EBIT growth 3Y9.86%
EBIT growth 5Y16.32%
EBIT Next Year173.33%
EBIT Next 3Y46.68%
EBIT Next 5YN/A
FCF growth 1Y197.72%
FCF growth 3Y10.22%
FCF growth 5Y6.95%
OCF growth 1Y63.86%
OCF growth 3Y7.62%
OCF growth 5Y8.72%